新型4-oxobutanamide衍生物的设计,合成和抗瘤活性
Caiju Wu1, Jingliang He1, Hanxue Li1
1School of Pharmacy, Jiangsu Key Laboratory of Marine Bioresources and Environment, Jiangsu Ocean University, Lianyungang 222005, China.
Bioorganic & medicinal chemistry letters
|September 28, 2024
概括
新的4-oxobutanamide衍生物被合成用于对抗癌症. 化合物DN4对癌细胞表现出显著的抗瘤活性,性能优于现有的药物,并显示出作为一种新的癌症治疗方法的希望.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 癌症仍然是一个重大的全球健康挑战,需要开发新的,有效的,低毒性抗瘤剂.
- 分子杂交是一种有价值的策略,用于设计具有改善治疗特征的新药候选者.
研究的目的:
- 设计和合成具有潜在抗瘤活性的新型4-oxobutanamide衍生物.
- 评估这些化合物对人类癌症细胞系的抗增殖作用.
- 为了识别具有优越功效和有利的类似药物的物质的化合物.
主要方法:
- 通过分子杂交合成新型4-oxobutanamide衍生物的合成.
- 针对HeLa,MDA-MB-231和A498癌细胞系的体外抗增殖试验.
- 使用异种移植小鼠模型进行体内疗效研究.
- 吸收,分布,新陈代谢,分泌和毒性 (ADMET) 属性的体预测.
主要成果:
- 复合物DN4,一种苏胺衍生物,对A498细胞表现出强烈的抗增殖活性 (IC50 = 1.94μM),超过了帕克利塔塞尔和胆固醇.
- 根据剂量,DN4显著抑制了A498细胞的增殖,粘附,侵袭,血管生成和瘤生长.
- 预测的ADMET特性表明,DN4和相关衍生品具有适合进一步开发的类似药物的特性.
结论:
- 化合物DN4是开发新型抗癌疗法的非常有前途的候选者.
- 合成的4-oxobutanamide衍生物代表了癌症治疗研究中有价值的一类化合物.
- 需要对DN4的作用机制和临床疗效进行进一步的研究.
相关概念视频
Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Opioid Analgesics: Synthetic and Semisynthetic Opioids
239
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
239
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K


![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)